Earnings History Data for Compugen (CGEN) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Compugen

Compugen Ltd. is a pioneer in the fields of computational genomics and proteomics. The company combines the disciplines of mathematics and computer science with molecular biology to improve the understanding of genomics and proteomics, the study of genes and proteins. Compugen's expertise in these areas is used to develop core technologies and platforms that are the basis for its products and services. These products and services are designed to enable life scientists to significantly enhance their research efforts in drug discovery.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
05-03-2024	PM		CGEN	Compugen	223.00	0.11	0.10	0.00	Compugen GAAP EPS of $0.11 beats by $0.01, revenue of $33.46M beats by $13.46M [3/5/2024 7:01 AM]	2.56	-0.39 (-13.22%)	2.77	-0.18 (-6.10%)	0.53 - 2.99	2,038,533	760,000	722,949
Compugen Q4 2023 Earnings Preview [3/4/2024 11:02 AM] Compugen GAAP EPS of $0.11 beats by $0.01, revenue of $33.46M beats by $13.46M [3/5/2024 7:01 AM]
07-11-2023	PM		CGEN	Compugen Ltd.	64.29	-0.11	-0.09	-0.14	Compugen GAAP EPS of -$0.11 misses by $0.02 [11/7/2023 7:06 AM]	0.6911	-0.03 (-4.57%)	0.72	-0.01 (-0.90%)	0.55 - 1.49	331,162	160,000	10,064
Compugen Q3 2023 Earnings Preview [11/6/2023 1:12 PM] Compugen GAAP EPS of -$0.11 misses by $0.02 [11/7/2023 7:06 AM]
07-08-2023	PM		CGEN	Compugen Ltd.	97.01	-0.11	-0.13	-0.11	Compugen GAAP EPS of -$0.11 beats by $0.02 [8/7/2023 7:02 AM]	1.02	-0.10 (-9.03%)	1.16	0.04 (3.57%)	0.51 - 1.56	370,794	280,000	11,482
Compugen GAAP EPS of -$0.11 beats by $0.02 [8/7/2023 7:02 AM]
15-05-2023	PM	7:00 AM ET (May 15)	CGEN	Compugen Ltd.	64.97	-0.11	-0.12	-0.11	Compugen GAAP EPS of -$0.11 beats by $0.01 [5/15/2023 7:03 AM]	0.8275	0.09 (11.79%)	0.76	0.02 (2.68%)	0.51 - 2.36	550,346	300,000	19,781
Compugen GAAP EPS of -$0.11 beats by $0.01 [5/15/2023 7:03 AM]
27-02-2023	PM	7:00 AM ET (Feb 27)	CGEN	Compugen Ltd.	68.61	-0.04	-0.14	-0.10	Compugen reports Q4 earnings; initiates FY23 cash burn guidance [2/27/2023 7:02 AM]	0.7616	0.02 (2.17%)	0.76	0.02 (2.28%)	0.51 - 3.57	177,456	420,000	120,268
Compugen reports Q4 earnings; initiates FY23 cash burn guidance [2/27/2023 7:02 AM]
14-11-2022	PM	7:00 AM ET (Nov 14)	CGEN	Compugen Ltd.	72.76	-0.14	-0.13	-0.07	Compugen GAAP EPS of -$0.14 misses by $0.01 [11/14/2022 7:02 AM]	0.8410	-0.08 (-8.59%)	0.91	-0.01 (-1.09%)	0.51 - 6.05	526,524	790,000	38,964
Compugen GAAP EPS of -$0.14 misses by $0.01 [11/14/2022 7:02 AM] Compugen Reports Third Quarter 2022 Results [Nov-14-22 07:00AM]
04-08-2022	PM	7:00 AM ET (Aug 4)	CGEN	Compugen Ltd.	159.95	-0.11	-0.12	-0.11	Compugen GAAP EPS of -$0.11 beats by $0.01 [8/4/2022 7:09 AM]	1.54	-0.08 (-4.94%)	3.92	-0.40 (-9.26%)	1.49 - 7.48	1,651,132	730,000	51,552
Compugen Q2 2022 Earnings Preview [8/3/2022 12:44 PM] Compugen GAAP EPS of -$0.11 beats by $0.01 [8/4/2022 7:09 AM]
16-05-2022	PM	7:00 AM ET (May 16)	CGEN	Compugen Ltd.	162.54	-0.11	-0.12	-0.12	Compugen GAAP EPS of -$0.11 beats by $0.01 [5/16/2022 7:06 AM]	1.95	0.02 (1.04%)	1.97	0.04 (2.07%)	1.66 - 9.20	691,423	1,210,000	9,478
Compugen GAAP EPS of -$0.11 beats by $0.01 [5/16/2022 7:06 AM] Companies Like Compugen (NASDAQ:CGEN) Are In A Position To Invest In Growth [May-13-22 09:27AM] Compugen Reports First Quarter 2022 Results [May-16-22 07:00AM]
24-02-2022	PM	7:00 AM ET (Feb 24)	CGEN	Compugen Ltd.	235.81	-0.10	-0.15	-0.10	Compugen GAAP EPS of -$0.10 beats by $0.04 [2/24/2022 7:06 AM]	2.76	-0.05 (0.00%)	0.0	0.0 (0.00%)	2.72 - 10.99	938,705	1,064,950	0
Compugen Q4 2021 Earnings Preview [2/23/2022 1:57 PM] Compugen GAAP EPS of -$0.10 beats by $0.04 [2/24/2022 7:06 AM] Compugen Reports Fourth Quarter and Full Year 2021 Results [Feb-24-22 07:00AM] Compugen Announces Appointment of Dr. Mathias Hukkelhoven to its Board of Directors [Feb-24-22 07:05AM]
12-11-2021	PM	7:00 AM ET (Nov 12)	CGEN	Compugen Ltd.	527.00	-0.07	-0.12	-0.09	Compugen EPS beats by $0.05 [11/12/2021 7:04 AM]	5.86	-1.30 (-18.16%)	6.26	-0.90 (-12.57%)	5.60 - 15.16	5,478,400	1,830,000	519,911
Compugen posts early Phase 1 data for anti-TIGIT antibody in advanced solid tumors [11/12/2021 8:18 AM] Compugen EPS beats by $0.05 [11/12/2021 7:04 AM] Bristol-Myers Squibb completes $20M investment in Compugen [11/11/2021 7:27 AM] Why Compugen Surged 14% Higher on Thursday [Nov-11-21 06:05PM] Compugen's stock jumps after Bristol Myers Squibb completes $20 million investment into the company [Nov-11-21 08:22AM] The Daily Biotech Pulse: Eisai-Gilead Tout Positive Phase 2 Data For New Alzheimer's Treatment, Compugen Spikes On Bristol-Myers Investment, Vaxxinity Debuts [Nov-11-21 08:03AM] Compugen Announces Collaboration Expansion with Bristol Myers Squibb alongside $20 Million Equity Investment [Nov-11-21 07:00AM] Compugen Stock Jumps After Bristol Myers Squibb Invests $20M [Nov-11-21 04:55AM] Compugen Reports Third Quarter 2021 Results [Nov-12-21 07:00AM] Compugen Presents Preliminary Results from Phase 1/2 Dose Escalation Study of COM701 with Opdivo® and BMS-986207 (Anti-TIGIT Antibody) at SITC 2021 [Nov-12-21 07:00AM] Compugen Presents Preliminary Results from Phase 1 Dose Escalation Monotherapy Study of COM902 a High Affinity Anti-TIGIT Antibody at SITC 2021 [Nov-12-21 07:00AM] Compugen Presents Initial Translational Data Supporting the Differentiation of PVRIG Compared to TIGIT and PD-1 as a Novel Checkpoint on the DNAM Axis at SITC 2021 [Nov-12-21 07:00AM] Compugen (CGEN) Stock Up on Bristol Myers' $20M Investment [Nov-12-21 10:07AM]
28-07-2021	PM	7:00 AM ET (Jul 28)	CGEN	Compugen Ltd.	558.12	-0.11	-0.12	-0.08	Compugen EPS beats by $0.01 [7/28/2021 7:02 AM]	6.88	0.50 (7.84%)	6.88	0.0 (0.00%)	6.12 - 19.90	836,470	790,000	2,378
Compugen EPS beats by $0.01 [7/28/2021 7:02 AM] Compugen posts Q2 results, provides cash position update [7/28/2021 10:07 AM] Compugen Reports Second Quarter 2021 Results [Jul-28-21 07:00AM] Why Compugen Stock Is Jumping Today [Jul-28-21 12:12PM]
13-05-2021	PM	7:05 AM ET (May 13)	CGEN	Compugen Ltd.	634.69	-0.12	-0.12	-0.10	Compugen EPS beats by $0.01 [5/13/2021 7:05 AM]	7.41	0.54 (7.86%)	7.41	0.0 (0.00%)	6.74 - 19.90	1,729,741	1,030,000	1,216
Compugen Q1 Earnings Preview [5/12/2021 11:32 AM] Compugen EPS beats by $0.01 [5/13/2021 7:05 AM] Compugen Ltd. to Host Earnings Call [May-13-21 06:30AM] Compugen Reports First Quarter 2021 Results [May-13-21 07:00AM] Why Compugen Stock Is Jumping Today [May-13-21 11:40AM] Compugen Ltd. (CGEN) Q1 2021 Earnings Call Transcript [May-13-21 08:30PM]
25-02-2021	PM	7:00 AM ET (Feb 25)	CGEN	Compugen Ltd.	1,060	-0.10	-0.10	-0.10	Compugen EPS in-line [2/25/2021 7:09 AM]	8.93	-1.44 (-13.85%)	10.81	0.45 (4.34%)	5.94 - 19.90	3,948,490	1,353,510	101,292
Compugen EPS in-line [2/25/2021 7:09 AM] Compugen Q4 Earnings Preview [2/24/2021 11:52 AM] Compugen's COM701 Shows Ongoing Durable Signals In Early-Stage Solid Tumor Studies [Feb-25-21 08:21AM] Compugen Reports Fourth Quarter and Full Year 2020 Results [Feb-25-21 07:05AM] Compugen Announces Data Update from COM701 Phase 1 Clinical Trial [Feb-25-21 07:00AM] Compugen Ltd. to Host Earnings Call [Feb-25-21 06:30AM]
05-11-2020	PM	7:00 AM ET (Nov 5)	CGEN	Compugen Ltd.	1,080	-0.09	-0.09	-0.10	Compugen EPS in-line [11/5/2020 7:07 AM]	14.11	0.50 (3.67%)	14.11	0.0 (0.00%)	4.76 - 19.90	1,366,491	869,410	25,314

30-07-2020	PM	7:00 AM ET (Jul 30)	CGEN	Compugen Ltd.	1,140	-0.08	-0.10	-0.10	Compugen EPS beats by $0.02 [7/30/2020 7:01 AM]	15.39	1.11 (7.77%)	14.14	-0.14 (-0.98%)	2.96 - 17.85	793,267	1,161,648	2,965

06-05-2020	PM		CGEN	Compugen Ltd.	1,140	-0.10	-0.10	-0.14	Compugen EPS in-line [5/6/2020 7:09 AM]	14.71	-0.23 (-1.54%)	14.88	0.17 (1.16%)	2.73 - 15.30	716,248	1,382,374	6,390